Roodabeh Bahramsoltani

Roodabeh Bahramsoltani

Auto-generated profile, based on publicly available information

Roodabeh Bahramsoltani

Tehran University of Medical Sciences

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YTYasamin Davatgaran Taghipour
Yasamin Davatgaran Taghipour
SMSalar Masoomzadeh
Salar Masoomzadeh
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
ZKZahra Karimi-Soureh
Zahra Karimi-Soureh
MAMohammad Abdollahi
Mohammad Abdollahi
Cancer is defined as the abnormal cell growth that can cause life-threatening malignancies with high financial costs for patients as well as the health care system. Natural polyphenols have long been used for the prevention and treatment of several disorders due to their antioxidant, anti-inflammatory, cytotoxic, antineoplastic, and immunomodulatory effects discussed in the literature; thus, these phytochemicals are potentially able to act as chemopreventive and chemotherapeutic agents in different types of cancer. One of the problems regarding the use of polyphenolic compounds is their low bioavailability. Different types of formulations have been designed for the improvement of bioavailability of these compounds, nanonization being one of the most notable approaches among them. This study aimed to review current data on the nanoformulations of natural polyphenols as chemopreventive and chemotherapeutic agents and to discuss their molecular anticancer mechanisms of action. Nanoformulations of natural polyphenols as bioactive agents, including resveratrol, curcumin, quercetin, epigallocatechin-3-gallate, chrysin, baicalein, luteolin, honokiol, silibinin, and coumarin derivatives, in a dose-dependent manner, result in better efficacy for the prevention and treatment of cancer. The impact of nanoformulation methods for these natural agents on tumor cells has gained wider attention due to improvement in targeted therapy and bioavailability, as well as enhancement of stability. Today, several nanoformulations are designed for delivery of polyphenolic compounds, including nanosuspensions, solid lipid nanoparticles, liposomes, gold nanoparticles, and polymeric nanoparticles, which have resulted in better antineoplastic activity, higher intracellular concentration of polyphenols, slow and sustained release of the drugs, and improvement of proapoptotic activity against tumor cells. To conclude, natural polyphenols demonstrate remarkable anticancer potential in pharmacotherapy; however, the obstacles in terms of their bioavailability in and toxicity to normal cells, as well as targeted drug delivery to malignant cells, can be overcome using nanoformulation-based technologies, which optimize the bioefficacy of these natural drugs.

1 January 2020 in Pharmacological Research
Verified
Journal Article
Closed access
SSsorraya sajadi
sorraya sajadi
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
Amin IranpanahAmin Iranpanah
Amin Iranpanah
Jayanta Kumar PatraJayanta Kumar Patra
Jayanta Kumar Patra
GDGITISHREE DAS
GITISHREE DAS
Jianbo XiaoJianbo Xiao
Jianbo Xiao

30 October 2016 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
MAMohammad Abdollahi
Mohammad Abdollahi
RRRoja Rahimi
Roja Rahimi
Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Mohammad Abdollahi, Roja Rahimi. J Neurogastroenterol Motil 1999;0:. http://dx.doi.org/10.5056/jnm16001

4 June 2014 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
RRRoja Rahimi
Roja Rahimi

1 September 2017 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
RRRoja Rahimi
Roja Rahimi
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei

1 December 2015 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
RBRoodabeh Bahramsoltani
Roodabeh Bahramsoltani
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
MFMarzieh Sarbandi Farahani
Marzieh Sarbandi Farahani
RRRoja Rahimi
Roja Rahimi
Depression is a major mental disease that is ranked as the fourth leading cause of disability. In order to avoid unwanted adverse reactions, as well as improve efficacy, current researches are seeking alternatives to conventional antidepressants. Phytochemicals provide an extensive research area in antidepressant therapies. The aim of the present study is to comprehensively review neurological evidences demonstrating the efficacy of phytochemicals in depression. For this purpose, electronic databases were searched to collect all data on the antidepressant mechanisms of phytochemicals from 1966 up to 2015. Plant metabolites from different categories including polyphenols (flavonoids, phenolic acids, lignanes, coumarins), alkaloids, terpenes and terpenoids, saponins and sapogenins, amines, and carbohydrates were found to possess antidepressant activity. Naringenin, quercetin derivatives, eugenol, piperine, diterpene alkaloids, berberine, hyperforin, riparin derivatives, ginsenosides, as well as β-carboline alkaloids are among the most relevant ones. Naringenin has represented its antidepressant effect by elevation of serotonin (5-HT), norepinephrine, brain-derived neurotrophic factor (BDNF), and glucocorticoid receptors. Piperine demonstrated inhibition of monoamine oxidase enzymes, elevation of brain 5-HT and BDNF levels, and modulation of the hypothalamus-pituitary-adrenal axis. The serotonergic, noradrenergic, and dopaminergic effect of berberine has been proven in several studies. Quercetin derivatives have revealed antidepressant potential via elevating pro-opiomelanocortin and neuroprotective properties, as well as reduction of proinflammatory cytokines. Assessing the structure-activity relationship of highly potent antidepressant phytochemicals is suggested to find future natural, semisynthetic, or synthetic antidepressants. Further clinical studies are also necessary for confirmation of natural antidepressant efficacy and completion of their safety profile.